Hedge Fund - FinePoint Capital
Acadia Pharmaceuticals Inc (ACAD)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q4 (2024-12-31) | $0 | 0% | 0 | $16.14 |
| 2 | 2024 - Q3 (2024-09-30) | $13,924,806 | 1.01% | 905,384 | $16.68 |
| 3 | 2024 - Q2 (2024-06-30) | $14,712,490 | 4.17% | 905,384 | $16.14 |
| 4 | 2024 - Q1 (2024-03-31) | $15,539,976 | 3.98% | 840,453 | $24.78 |
| 5 | 2023 - Q4 (2023-12-31) | $24,097,835 | 7.6% | 769,653 | $23.88 |
| 6 | 2023 - Q3 (2023-09-30) | $11,598,565 | 5.77% | 556,553 | $27.16 |
| 7 | 2023 - Q2 (2023-06-30) | $20,284,524 | 7.01% | 846,953 | $22.23 |
| 8 | 2023 - Q1 (2023-03-31) | $17,245,763 | 6.58% | 916,353 | $19.05 |
| 9 | 2022 - Q4 (2022-12-31) | $18,735 | 6.05% | 1,176,830 | $15.63 |
| 10 | 2022 - Q3 (2022-09-30) | $18,176,000 | 5.97% | 1,111,030 | $16.19 |
| 11 | 2022 - Q2 (2022-06-30) | $9,964,000 | 3.44% | 707,200 | $18.68 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center